Immunogenic oncolysis by tigilanol tiglate
Tigilanol tiglate is an oncolytic small molecule that is undergoing clinical trials. A recent study revealed the capacity of this pyroptosis inducer to elicit hallmarks of immunogenic cell death. In addition, intratumoral injection of tigilanol tiglate can sensitize subcutaneous cancers to subsequen...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis Group
2024-12-01
|
| Colecção: | OncoImmunology |
| Assuntos: | |
| Acesso em linha: | https://www.tandfonline.com/doi/10.1080/2162402X.2024.2360230 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|